ANG Lifesciences India Ltd - 540694 - Closure of Trading Window
Intimation of Closure of Trading Window29-06-2024
29-06-2024
ANG Lifesciences India Ltd - 540694 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015.
We are pleased to informed you that a unit III of Ind-Swift Ltd has now been legitimately registered in the name of ANG Lifesciences India Limited as Unit V. Further details are enclosed herewith disclosure.27-06-2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Reg 30 & 47 of SEBI(LODR) Regulations, 2015, enclosed are the copies of Newspaper advertisements of Audited Financial Results of quarter and year ended at 31.03.2024.13-06-2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Cessation
Resignation of Mr. Pawanjit Singh w.e.f 28.05.2024 due to completion of his tenure.13-06-2024
ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for FY 2023-2430-05-2024
ANG Lifesciences India Ltd - 540694 - Financial Result For Quarter And Year Ended As At 31.03.2024
Financial Result (Standalone & Consolidated) for quarter and year ended as at 31.03.202430-05-2024
ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting
Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended 31st March, 2024. The said Audited Financial Results were reviewed by Audit Committee and thereafter approved by the Board of Directors.30-05-2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates
In pursuant to Reg. 30 of SEBI LODR, 2015, The Board of Directors of the company appointed Mr. Harvinder Singh as an Additional Director in the capacity of Independent Director w.e.f. 27.05.202427-05-2024
ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Approval Of Audited Financial Standalone And Consolidated Statements For Quarter And Year Ended 31.03.2024.
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. The Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2024. 2. Any other business that may be necessary with the permission of Chairman.24-05-2024
ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates
As per regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mrs. Saruchi Gupta has been appointed as Chief Financial Officer of the company on the recommendation of Nomination and Remuneration Committee.13-05-2024